Fireside Chat: Effectively Operationalizing Clinical Trials in Immune Resetting Therapeutics

  • Securing Centre’s of Excellence with necessary oncology and rheumatology clinical expertise for patient screening lymphodepletion and toxicity management
  • Addressing the competitive landscape around securing sites and managing site capacity that can risk delaying trial activation and delaying patient enrolment
  • Improving patient enrolment practices through streamlining the patient journey, site education and increasing the centralization of trials to be more accessible